Company profile
Zura Bio Ltd
NASDAQ:ZURABiotechnology: Biological Products (No Diagnostic Substances)
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06993610 | phase2 | active_not_recruiting | 2025-05-16 | 2026-11-01 | Zura Bio Inc | Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense |
| NCT06843239 | phase2 | active_not_recruiting | 2025-02-06 | 2027-05-01 | Zura Bio Inc | Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) |
FDA applications (0)
No records yet.